Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
ZEC continues to rise, what are some privacy-focused projects worth paying attention to in the space?
ZEC continues to rise, what are some privacy-focused projects worth paying attention to in the space?

Betting on privacy is actually betting on freedom

BlockBeats·2025/11/03 07:42
SUI News Today: Investors Consider Blazpay's Presale Pressure Versus Sui's Volatile Surge
SUI News Today: Investors Consider Blazpay's Presale Pressure Versus Sui's Volatile Surge

- Blazpay's AI-powered Layer 1 token presale nears 94% completion, raising $1M with 25% price hike imminent. - Sui (SUI) shows bullish technical indicators, targeting $3.00 as it stabilizes above $2.28 amid growing DeFi adoption. - Both projects position as high-growth AI-integrated blockchain alternatives to legacy platforms like Tron and Solana. - Blazpay's $0.0075 presale offers asymmetric upside potential, with $3K investment projecting $80K gains if reaching $0.20 post-listing. - Sui faces $653M token

Bitget-RWA·2025/11/03 07:42
Bitcoin Updates: U.S.-China Agreement Brings Optimism to Crypto, Yet Concerns and Regulatory Barriers Slow Rebound
Bitcoin Updates: U.S.-China Agreement Brings Optimism to Crypto, Yet Concerns and Regulatory Barriers Slow Rebound

- Crypto Fear & Greed Index at 42 signals persistent caution despite U.S.-China trade deal delaying tariffs until 2026. - Hong Kong regulators block DAT structures over valuation risks, while Brazil's 30% crypto tax proposal adds regulatory uncertainty. - Ethereum near $3,700 support level with $959M in long liquidation risks, as token unlocks across ENA/SOL/DOGE threaten short-term volatility. - Analysts urge combining sentiment indicators with fundamentals, noting October's $19B liquidation event and Bit

Bitget-RWA·2025/11/03 07:42
ETH falls below $3,700
ETH falls below $3,700

Cointime·2025/11/03 07:18
Tron's USDT Growth Drives Financial Access for 500 Million Without Bank Accounts
Tron's USDT Growth Drives Financial Access for 500 Million Without Bank Accounts

- Tron's network activity hit a two-year high with 11.1M active addresses and 12.6M daily transactions, driven by USDT's dominance. - The 69% weekly address surge reflects organic growth, outpacing major blockchains while maintaining low-cost, high-speed transactions. - USDT processes 15-20M weekly transactions on Tron, serving 500M users in emerging markets as a tool for financial inclusion. - Tron's $78.7B USDT circulation rivals Ethereum's $83.4B, showcasing its efficiency in handling high-volume stable

Bitget-RWA·2025/11/03 07:08
Flash
12:11
Fortune and Predict.fun complete liquidity integration, AI Bot tool officially launched
ChainCatcher news, the prediction market infrastructure platform Fortune announced it has reached another significant milestone: its core AI products, AI Bot and Sports Agent, have officially debuted. Fortune AI is positioned as an “AI operating system” for prediction market traders, capable of monitoring news trends, market sentiment, and arbitrage signals in real-time. It provides selective operations through a structured decision and execution pipeline, unlocking comprehensive intelligence for prediction trading. Previously, Fortune successfully integrated Predict.fun’s prediction market liquidity, significantly improving users’ trading options and depth. With the launch of the AI Bot automated trading tool, Fortune has further enhanced its dual-driven strategy of “liquidity + intelligence.” Fortune officials stated that they remain committed to a user-centric approach, aiming to provide a convenient and efficient one-stop prediction experience for users worldwide.
12:10
Core & Main, Inc. announces plans to use a portion of its funds to prepay its senior term loan due July 27, 2028.
This move aims to optimize the company’s debt structure and reduce financial costs. In addition, the remaining funds will be used for general corporate purposes to support its daily operations and strategic development. This financial measure reflects the company’s solid cash flow management capabilities and its positive planning for future growth.
12:10
Kymera Therapeutics announced that patient enrollment has been completed for its mid-stage clinical trial targeting eczema.
Boosted by this news, the company’s stock price surged by 10.2% during pre-market trading. This development marks a key milestone in one of the company’s major R&D projects, paving the way for subsequent data analysis and clinical results evaluation. The market holds positive expectations for potential outcomes of this trial, which has driven the notable rise in the stock price.
Markets